Latest market price
8.02
-0.46-5.42%
OverviewShort InterestFilings
IOVAQT69Iovance Biotherapeutics, Inc.·NASDAQ
8.02-5.42%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 29, 20268-KCurrent report
Oct 05, 20268-KCurrent report
Oct 02, 20264Statement of changes in beneficial ownership
Oct 02, 20263Initial statement of beneficial ownership
Sep 29, 20268-KCurrent report
Sep 10, 20264Statement of changes in beneficial ownership
Sep 10, 20264Statement of changes in beneficial ownership
Sep 10, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 10, 20264Statement of changes in beneficial ownership
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Aug 06, 20268-KCurrent report
Jul 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 02, 20268-KCurrent report
Jun 18, 2026S-8Registration of employee benefit securities
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 2026S-8Registration of employee benefit securities
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
#1 / 25 of 374
Page
▼
/ 15